You are here

Initiating Treatment

Active Resources: 10

  • The NHC offers free online continuing education for novice-to-expert health professionals, students, and faculty.

    Type: Online and Self-Paced Learning
    Publish Date: 9/14/2020
  • Slides from a 1-day course for primary care physicians and mid-level clinicians, which combines the latest research with current treatment guidelines for managing patients with HIV.

    Type: Training Materials
    Publish Date: 7/31/2020
  • Training slides covering U.S. HHS treatment recommendations related to starting antiretroviral therapy (ART) in people with HIV infection.

    Type: Training Materials
    Publish Date: 3/1/2020
  • Excerpt from the Guidelines Introduction: "The Department of Health and Human Services (HHS) Panel on Antiretroviral Guidelines for Adults and Adolescents (the Panel) is a working group of

    Type: Guidelines
    Publish Date: 12/18/2019
  • Each year HRSA's HIV/AIDS Bureau sponsors a conference for Ryan White Program clinicians to learn about advances in care and treatment.

    Type: Online and Self-Paced Learning
    Publish Date: 12/4/2019
  • In response to newly identified, community-based HIV epidemics, the AETC NCRC has pulled together the following AETC Program and U.S.

    Type: Clinical Reference Tools
    Publish Date: 6/10/2019
  • This glossary of HIV/AIDS-related terms includes brief lay-oriented descriptions and illustrations. Materials are in the public domain and may be used freely.

    Type: Clinical Reference Tools
    Publish Date: 2/20/2019
    Review Date: 2/20/2019
  • Immediate antiretroviral therapy (ART) means starting HIV treatment as soon as possible after the diagnosis of HIV infection, preferably on the first clinic visit (and even on the same day as the H

    Type: Guidelines
    Publish Date: 2/14/2019
  • Seven popular clinical resources covering HIV testing, prevention (PrEP and PEP), rapid ART, and HIV primary care, to be used in diverse clinical settings.

    Type: Clinical Reference Tools
    Publish Date: 12/11/2018
  • To help HIV care providers engage patients in care and transmission prevention, the Centers for Disease Control and Prevention (CDC) developed a new and comprehensive Prevention IS Care re

    Type: Clinical Reference Tools
    Publish Date: 5/17/2016
    Review Date: 2/20/2019

Archive Resources: 3

Articles: 5

  • FDA Approves 2-Drug Combination of Dolutegravir + Lamivudine

    Susa Coffey's picture

    In April 2019, the U.S. Food and Drug Administration approved a combination pill comprising the integrase inhibitor dolutegravir (DTG), 50 mg, and the NRTI lamivudine (3TC), 300 mg, for use as a complete ARV regimen for initial HIV treatment of patients. The approval specifies that DTG/3TC is...

  • Immediate ART Initiation: Guide for Clinicians

    Susa Coffey's picture

    Immediate antiretroviral therapy (ART) refers to starting HIV treatment as soon as possible after the diagnosis of HIV infection, preferably on the first clinic visit (and even on the same day the HIV diagnosis is made). This strategy also is known as "rapid ART," "same-day ART," and "treatment...

  • Doravirine in Initial Therapy: DRIVE-AHEAD Study

    Susa Coffey's picture

    Doravirine (DOR) is an investigational NNRTI that currently is being developed in a coformulation with TDF and FTC. A Phase 3 comparison of DOR + 2 NRTIs (87% of study subjects were given TDF/FTC) and DRV/r + 2 NRTIs in initial therapy was presented at CROI earlier this year (DRIVE-FORWARD); the...

  • Bictegravir in Initial Therapy

    Susa Coffey's picture

    Bictegravir (BIC) is an investigational integrase inhibitor that is being studied as part of a coformulation with tenofovir alafenamide (TAF) and emtricitabine (FTC). Two Phase 3 trials comparing a single-tablet regimen of BIC/TAF/FTC (50/25/200 mg) with regimens containing dolutegravir (DTG)...

  • START-ing TEMPRANO: Early Initiation of Antiretroviral Therapy for HIV

    Jennifer Cocohoba's picture

    The prevailing opinion among experts regarding the optimal CD4 T-cell count at which to start patients on antiretroviral therapy (ART) has shifted several times during the evolution of HIV treatment. These shifts reflect attempts to strike a balance between preventing HIV-associated illness and...